151 related articles for article (PubMed ID: 10231397)
21. Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression.
Vargas AC; McCart Reed AE; Waddell N; Lane A; Reid LE; Smart CE; Cocciardi S; da Silva L; Song S; Chenevix-Trench G; Simpson PT; Lakhani SR
Breast Cancer Res Treat; 2012 Aug; 135(1):153-65. PubMed ID: 22718308
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of beta1-chain-containing laminins in capillary basement membranes of human breast cancer and its metastases.
Fujita M; Khazenzon NM; Bose S; Sekiguchi K; Sasaki T; Carter WG; Ljubimov AV; Black KL; Ljubimova JY
Breast Cancer Res; 2005; 7(4):R411-21. PubMed ID: 15987446
[TBL] [Abstract][Full Text] [Related]
23. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma.
Rasbridge SA; Gillett CE; Sampson SA; Walsh FS; Millis RR
J Pathol; 1993 Feb; 169(2):245-50. PubMed ID: 8383197
[TBL] [Abstract][Full Text] [Related]
24. Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition.
Gudjonsson T; Rønnov-Jessen L; Villadsen R; Rank F; Bissell MJ; Petersen OW
J Cell Sci; 2002 Jan; 115(Pt 1):39-50. PubMed ID: 11801722
[TBL] [Abstract][Full Text] [Related]
25. Cellular expression of growth hormone and prolactin receptors in human breast disorders.
Mertani HC; Garcia-Caballero T; Lambert A; Gérard F; Palayer C; Boutin JM; Vonderhaar BK; Waters MJ; Lobie PE; Morel G
Int J Cancer; 1998 Apr; 79(2):202-11. PubMed ID: 9583737
[TBL] [Abstract][Full Text] [Related]
26. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions.
Barth PJ; Ebrahimsade S; Ramaswamy A; Moll R
Virchows Arch; 2002 Mar; 440(3):298-303. PubMed ID: 11889601
[TBL] [Abstract][Full Text] [Related]
27. D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma.
Rabban JT; Chen YY
Hum Pathol; 2008 Feb; 39(2):175-83. PubMed ID: 18206495
[TBL] [Abstract][Full Text] [Related]
28. [Methylation of Runx3 promoter in different breast lesions].
Wang X; Zheng X; Lin X; Shi Y; He Y; Chen G
Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):447-50. PubMed ID: 25327792
[TBL] [Abstract][Full Text] [Related]
29. Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma.
Kosmehl H; Berndt A; Strassburger S; Borsi L; Rousselle P; Mandel U; Hyckel P; Zardi L; Katenkamp D
Br J Cancer; 1999 Nov; 81(6):1071-9. PubMed ID: 10576667
[TBL] [Abstract][Full Text] [Related]
30. The functions of exogenous and endogenous laminin-5 on corneal epithelial cells.
Ebihara N; Mizushima H; Miyazaki K; Watanabe Y; Ikawa S; Nakayasu K; Kanai A
Exp Eye Res; 2000 Jul; 71(1):69-79. PubMed ID: 10880277
[TBL] [Abstract][Full Text] [Related]
31. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
32. Gene expression and protein deposition of major basement membrane components and TGF-beta 1 in human breast cancer.
Nerlich AG; Wiest I; Wagner E; Sauer U; Schleicher ED
Anticancer Res; 1997; 17(6D):4443-9. PubMed ID: 9494547
[TBL] [Abstract][Full Text] [Related]
33. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
34. Apoptosis-related proteins (Fas, Fas ligand, bcl-2 and p53) in different types of human breast tumors.
Ben-Hur H; Mordechay E; Halperin R; Gurevich P; Zandbank J; Herper M; Zusman I
Oncol Rep; 2002; 9(5):977-80. PubMed ID: 12168058
[TBL] [Abstract][Full Text] [Related]
35. The transcriptional regulator TBX3 promotes progression from non-invasive to invasive breast cancer.
Krstic M; Macmillan CD; Leong HS; Clifford AG; Souter LH; Dales DW; Postenka CO; Chambers AF; Tuck AB
BMC Cancer; 2016 Aug; 16(1):671. PubMed ID: 27553211
[TBL] [Abstract][Full Text] [Related]
36. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast.
Barbareschi M; Pecciarini L; Cangi MG; Macrì E; Rizzo A; Viale G; Doglioni C
Am J Surg Pathol; 2001 Aug; 25(8):1054-60. PubMed ID: 11474290
[TBL] [Abstract][Full Text] [Related]
37. The spectrum of 67-kD laminin receptor expression in breast carcinoma progression.
Viacava P; Naccarato AG; Collecchi P; Ménard S; Castronovo V; Bevilacqua G
J Pathol; 1997 May; 182(1):36-44. PubMed ID: 9227340
[TBL] [Abstract][Full Text] [Related]
38. Loss of ALX4 expression in epithelial cells and adjacent stromal cells in breast cancer.
Chang H; Mohabir N; Done S; Hamel PA
J Clin Pathol; 2009 Oct; 62(10):908-14. PubMed ID: 19783719
[TBL] [Abstract][Full Text] [Related]
39. Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer.
Siitonen SM; Kononen JT; Helin HJ; Rantala IS; Holli KA; Isola JJ
Am J Clin Pathol; 1996 Apr; 105(4):394-402. PubMed ID: 8604681
[TBL] [Abstract][Full Text] [Related]
40. Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function.
Sarper M; Allen MD; Gomm J; Haywood L; Decock J; Thirkettle S; Ustaoglu A; Sarker SJ; Marshall J; Edwards DR; Jones JL
Breast Cancer Res; 2017 Mar; 19(1):33. PubMed ID: 28330493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
